APA (7th ed.) Citation
Wang, Z., Guo, Y., Qin, X., Wan, Z., Wu, X., & Liu, C. (2026). Bevacizumab Plus EGFR-TKIs vs EGFR-TKIs Alone for Advanced EGFR-Mutant NSCLC: A Meta-Analysis. Clinical Medicine Insights: Oncology, 20, 1-19.
Chicago Style (17th ed.) Citation
Wang, Zexian, Yaru Guo, Xiaohan Qin, Zhiling Wan, Xiaojin Wu, and Chen Liu. "Bevacizumab Plus EGFR-TKIs Vs EGFR-TKIs Alone for Advanced EGFR-Mutant NSCLC: A Meta-Analysis." Clinical Medicine Insights: Oncology 20 (2026): 1-19.
MLA (9th ed.) Citation
Wang, Zexian, et al. "Bevacizumab Plus EGFR-TKIs Vs EGFR-TKIs Alone for Advanced EGFR-Mutant NSCLC: A Meta-Analysis." Clinical Medicine Insights: Oncology, vol. 20, 2026, pp. 1-19.
Warning: These citations may not always be 100% accurate.